Nov 12th, 2015

Why Valeant Is an Unusual Pharmaceutical Ethics Case

Greenhill & Co. CEO Scott Bok discusses the ethics of health care and pharmaceutical companies. He speaks on "Bloomberg ‹GO›." (Source: Bloomberg)

Top Video

Explore More

Duration:1:48

Oil Jumps as Trump Rebuffs Iran’s Offer

Daybreak: Europe

Duration:2:52

JPMorgan Says Equities at All-Time Highs 'Make Sense'

Duration:2:40

Trump, Xi Slated for Beijing Summit

Duration:2:24

Brent Has Found an 'Uneasy Equilibrium,' StanChart Says

Duration:1:37

Starmer's UK Leadership Woes Add to Gilt Risks, Rabobank Says

Duration:36:16

What If AI’s Biggest Impact Isn’t Jobs, But Minds?

Merryn Talks Money

Duration:3:31

Aramco Warns of Long Oil Market Disruption

Horizons Middle East & Africa

Duration:2:25

Modi Urges Indians to Cut Fuel Use as Prices Rise

Available on:

Listen onApple TVListen onRokuListen onSamsung TVListen onFire TVListen onAndroid TVListen onRakuten TVListen onHaystack News

Watch BTV in your area:

Channel Finder
Terms of ServiceTrademarksPrivacy Policy
CareersAdvertise
Ad Choices
Help©2026 Bloomberg L.P. All Rights Reserved.